PRO for Fighting FT in Ovarian Cancer
Condition: Ovarian Cancer Intervention: Other: Questionnaires Sponsor: National Cancer Institute, Naples Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
Condition: Ovarian Carcinoma Intervention: Drug: Sacituzumab govitecan Sponsors: Alessandro Santin; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials